Ledger.Open graph →
SEC Form D · filed July 15, 2019

Lucy Therapeutics, Inc

Offering
$3.5M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Sallie C. Squires · San Francisco, CADirectorBreellen Loughlin · Fitchburg, WIExec · DirectorJorge Olson · San Diego, CAExec · DirectorNeville Pearson · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Lucy Therapeutics, Inc. — SEC Form D filing (2019) | Ledger